Palforzia is a revolutionary new treatment for food allergies, offering hope to those with severe food allergies by reducing the risk of a severe allergic reaction. But who makes Palforzia, and what makes this treatment so effective? In this article, we’ll take a look at the company behind Palforzia and explore the science behind this groundbreaking new treatment.
Palforzia is a peanut allergen immunotherapy medication manufactured by Aimmune Therapeutics, Inc. It is the first FDA-approved treatment option for patients aged 4-17 with a confirmed diagnosis of peanut allergy. Palforzia works by gradually introducing small amounts of peanut allergen into the body, helping patients build a tolerance and potentially reduce the severity of allergic reactions.
Who Makes Palforzia?
Palforzia is a prescription drug used to treat peanut allergies in children and adults. It is manufactured by Aimmune Therapeutics, a biopharmaceutical company based in Brisbane, California. Aimmune was founded in 2011 and is dedicated to developing treatments that help patients manage food allergies.
History of Aimmune
Aimmune was founded by Rob Peter, a scientist and entrepreneur who was inspired by his daughter’s experience with food allergies. After months of research, he created a platform to develop treatments for food allergies, which eventually led to the development of Palforzia.
What is Palforzia?
Palforzia is a powder that is taken orally three times a day. It is designed to help reduce the severity of allergic reactions to peanuts by desensitizing patients to peanuts. It is the first and only FDA-approved treatment for peanut allergies.
How Does Palforzia Work?
Palforzia works by exposing patients to small, increasing doses of peanut protein over time. This helps the body build up a tolerance to peanuts, reducing the risk of severe allergic reactions.
Who Can Take Palforzia?
Palforzia is approved for use in patients 4 to 17 years old. It is not recommended for pregnant or breastfeeding women, and it should not be used by people who have a severe peanut allergy. It is important to talk to your doctor before starting Palforzia to make sure it is right for you.
Related FAQ
Who Makes Palforzia?
Answer: Palforzia is a peanut allergy immunotherapy drug manufactured by Aimmune Therapeutics, a biotechnology company based in Brisbane, California. Aimmune is focused on developing treatments for food allergies and has developed Palforzia as a therapeutic option for patients with peanut allergies.
What is Palforzia?
Answer: Palforzia is an oral immunotherapy treatment for individuals with peanut allergies. It is a powder made from peanut flour that is administered in gradually increasing doses to desensitize the patient to peanuts. The patient starts with a very low dose of the medication and gradually increases the dose over time until the patient can tolerate a certain amount of peanut-containing foods.
How Does Palforzia Work?
Answer: Palforzia works by desensitizing the immune system to peanuts. The drug is administered in gradually increasing doses, which triggers the immune system to become less reactive to peanuts. Over time, as the patient takes higher doses of the drug, the immune system becomes less likely to react to peanuts, reducing the risk of an allergic reaction.
What Are the Side Effects of Palforzia?
Answer: Palforzia can cause side effects, including stomach pain, nausea, vomiting, itching, hives, and difficulty breathing. In some cases, a severe allergic reaction known as anaphylaxis may occur. If a patient experiences any of these symptoms, they should seek immediate medical attention.
How is Palforzia Administered?
Answer: Palforzia is administered as an oral powder. The patient takes the powder with a liquid, such as water or milk, once a day. The dose of the powder is gradually increased over time until the patient is able to tolerate a certain amount of peanut-containing foods.
Who Should Not Take Palforzia?
Answer: Palforzia is not recommended for patients with severe peanut allergies or a history of anaphylaxis. It is also not recommended for patients who are taking certain medications, such as beta blockers, ACE inhibitors, or nonsteroidal anti-inflammatory drugs. Patients should consult with their healthcare provider before taking Palforzia.
In conclusion, Palforzia is a groundbreaking, FDA-approved peanut allergy treatment that has the potential to drastically improve the lives of those affected by peanut allergies. It is made by Aimmune Therapeutics, a biopharmaceutical company based in Brisbane, California, specializing in the development of products for food allergies. Through the development of Palforzia, Aimmune Therapeutics is setting a new standard for the management of peanut allergies, providing hope and relief to millions of individuals and families around the globe.